期刊文献+

P—PDGFR—α在胃肠道间质瘤和胃肠道外间质瘤的表达及其临床意义

The expression and clinical significance of p - PDGFR - α in gastrointestinal stromal tumors and extra- gastrointestinal stromal tumors
原文传递
导出
摘要 目的探讨磷酸化血小板源性生长因子受体α(P—PDGFR—α)在胃肠道间质瘤(GIST)和胃肠道外间质瘤(EGIST)的表达及临床意义,为进一步提高GIST的病理诊断、病理分型,及临床治疗提供有力的依据。方法用免疫组织化学方法(Envision)检测GIST中P-PDGFR—α的表达。结果P—PDGFR—α在CD117阴性的GIST表达显著高于在CD117阳性的GIST表达(P〈0.05);P—PDGFR—α在上皮型和混合型的GIST表达均显著高于在梭型细胞型GIST的表达(P〈0.05);CD117在梭型细胞型GIST的表达明显高于在上皮型和混合型GIST的表达(P〈0.05)。结论P—PDGFR—α对CD117阴性的GIST的病理诊断、病理分型和临床治疗进一步提供了可靠的依据。PDGFR—α基因突变后引起产物蛋白的磷酸化,可能是CD117阴性的GIST发生的重要分子基础和生物学行为。 Objective To explore the expression and clinical significance of phosphor - platelet derived growth factor receptor alpha (p- PDGFR -α) in gastrointestinal stromal tumors and extra- gastrointestinal stromal tumors, providing reliable evidence for further improvement of the pathological diagnosis, pathological typing and the clinical treatment of GIST, Methods The expression of p - PDGFR - α was detected with the method of envision immunohistochemical staining, Result The expression of p - PDGFR - α in the GISTs that were negative for CD117 is significantly higher than that in CD117 positive GISTs ( P 〈 0. 05 ). The expression of p -PDGFR -α in epithelioid GISTs and mixed GISTs both are significantly higher than that in fusiform GISTs ( P 〈0.05), The expression of CD117 in fusiform GISTs is significant higher than that in epithelioid GISTs and mixed GISTs ( P 〈 0. 05 ). Conclusions p - PDGFR - α detection can provide reliable evidence for the further improvement of the pathological diagnosis, pathological typing and the clinical treatment of GISTs that were CD117 negative. PDGFR -otmutations might induce protein phosphorylation, which may be the important alternative molecular mechanism and biological behavior for the development of GISTs that were CD117 negative.
作者 唐蜜 李代强
出处 《中国医师杂志》 CAS 2007年第4期479-481,共3页 Journal of Chinese Physician
关键词 胃肠道间质肿瘤 受体 血小板源生长因子α Gastrointestinal stromal tumors Receptor, platelet- derived growth factor alpha
  • 相关文献

参考文献11

  • 1Rubin BP, Singer S, Tsao C, et al. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res,2001,61 : 8118 -8121.
  • 2Heinrish MC, Corless CL, Duensing A, et al. PDGFR-αactivating mutation in gastrointestinal stromal tumors. Science ,2003,29:708-710.
  • 3Joensuu H, Roberts PJ, Sarkmo-Rikla M, et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal strmal tumor. N Engl J Med,2001,344(14) :1052-1056.
  • 4Hirota S, Ohashi A, Nishida T, et al. Gain-of-function mutations of platelet-defived growth factor receptor [ alpha ] gene in gastrointestinal stromal tumors. Gastroenterology, 2003,125:660-667.
  • 5Roskoski R Jr STI-571: an anticancer proein-tyrosine kinase inhibitor.Biocham B iophys Res Canmun ,2003,309 ( 4 ) : 709 -717.
  • 6Fletcherc, Berman JJ, Corless C, et al, Diagonsis of gastrointestinal stromal tumors a cansensus approach . Human pathol, 2002,33 ( 5 ) : 456-465.
  • 7Sakurai S, Hasegawa T, Sakuma Y, et al Myxoid epithelioid gastrointestinal stromal(GIST) with mast cell infiltrations a subtype of GIST with mutations of platelet-drived growth factor receptor alpha gene. Hum Pathol,2004,35 (10) : 1223-1230.
  • 8MarzurMJ, Clark HB, Gastric stromal tumors Resppraisal of histogenesis.AM J Surg Pathol, 1983,7 (6) :507-519.
  • 9朱青山,何清,刘基巍.65例胃肠道间质瘤临床分析[J].中国医师进修杂志,2006,29(8):48-50. 被引量:6
  • 10Duensing A, Heinrich MC, Fletcher CD, et al. Biology of gastrointestinal stromal tumors KIT mutaions and beyond. Cancer. Invest, 2004,22( 1 ) :106-116.

二级参考文献11

  • 1娄越亮,陈华,张燮良,战忠利.96例胃肠道间质瘤临床诊治分析[J].中华肿瘤杂志,2004,26(7):437-439. 被引量:25
  • 2金中高,徐炜,何剑,顾晓丽,祝跃明,吴晓,陈文华,张亮亮,宣浩波.胃肠道间质瘤的多层螺旋CT诊断[J].中国临床医学影像杂志,2005,16(3):149-152. 被引量:31
  • 3白月奎,邵永孚,石素胜,高燕宁,孙耘田,程书钧,刘秀云.胃肠道间质瘤预后多因素分析[J].中华肿瘤杂志,2005,27(10):598-601. 被引量:22
  • 4Fletcher CD,Berman JJ,Corless C,et al.Diagnosis of gastrointestinal stromal tumors:a consensus approach.Hum Pathol,2002,33 (5):459-465.
  • 5DeMatteo RP,Lewis JJ,Leung D,et al.Two hundred gastrointestinal stromal tumors:recurrence patterns and prognostic factors for survival.Ann Surg,2000,231 (1):51-58.
  • 6Demetri GD,von Mehren M,Blanke CD,et al.Efficacy and saftey of imatinib mesylate in advanced gastrointestinal stromal tumors.N Eng J Med,2001,347 (7):472-480.
  • 7Nilsson B,Bumming P,Meis-Kindblom JM,et al.Gastrointestinal stromal tumors:the incidence,prevalence,clinical course,and prog nostication in the preimatinib mesylate era-a population-based study in western Sweden.Cancer,2005,103 (4):821-829.
  • 8Ando N,Goto H,Niwa Y,et al.The diagnosis of GI stromal tumors with Eus-guided fine needle aspiration with immunohistochemical analysis.Gastrointest Endosc,2002,55(1):37-43.
  • 9周雷,王岩,姚力,裴斐,黄林平,王正康,贾振庚.胃肠道间质瘤的诊治及临床病理分析[J].中华普通外科杂志,2003,18(1):45-47. 被引量:54
  • 10曹斌,刘弋,陈德利,朱宝和.胃肠道间质瘤的诊治——附18例报告[J].医师进修杂志(外科版),2004,27(1):29-30. 被引量:2

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部